Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum
- 1 October 1998
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 39 (4) , 648-650
- https://doi.org/10.1016/s0190-9622(98)70020-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- TacrolimusDrugs, 1997
- Systemic Tacrolimus (FK 506) Is Effective for the Treatment of Psoriasis in a Double-blind, Placebo-Controlled StudyArchives of Dermatology, 1996
- Pyoderma gangrenosum: Classification and managementJournal of the American Academy of Dermatology, 1996
- Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointmentBritish Journal of Dermatology, 1995
- Efficacy of human intravenous immune globulin in pyoderma gangrenosumJournal of the American Academy of Dermatology, 1995
- The Mechanism of Action of FK‐506 and Cyclosporin AAnnals of the New York Academy of Sciences, 1993
- FK-506 and cyclosporin a: Selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulationBiochemical Pharmacology, 1991
- Pyoderma GangrenosumArchives of Dermatology, 1982